We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
-11.51%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$101M
AUM Growth
-$17.5M
Cap. Flow
-$4.67M
Cap. Flow %
-4.63%
Top 10 Hldgs %
44.39%
Holding
99
New
23
Increased
11
Reduced
26
Closed
11

Top Buys

1
ADVM
Adverum Biotechnologies
ADVM
+$1.8M
2
EPIX
ESSA Pharma
EPIX
+$1.59M
3
NEOS
Neos Therapeutics, Inc
NEOS
+$1.4M
4
WINT
Windtree Therapeutics Inc
WINT
+$1.28M
5
ABEO icon
Abeona Therapeutics
ABEO
+$965K

Top Sells

1
CLVS
Clovis Oncology, Inc.
CLVS
+$2.03M
2
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
+$1.66M
3
ATRC icon
AtriCure
ATRC
+$1.52M
4
DERM
Dermira, Inc.
DERM
+$832K
5
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
+$812K

Sector Composition

1 Healthcare 74.78%
2 Financials 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
1
AtriCure
ATRC
$1.75B
$10.7M 10.61%
487,946
-60,665
-11% -$1.52M
ABBV icon
2
AbbVie
ABBV
$436B
$6.34M 6.29%
116,581
– –
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
$5.78M 5.74%
366,554
– –
ZSPH
4
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$4.35M 4.31%
66,194
-906
-1% -$54.4K
ACHN
5
DELISTED
Achillion Pharmaceuticals
ACHN
$3.32M 3.29%
480,300
– –
BCRX icon
6
BioCryst Pharmaceuticals
BCRX
$2.41B
$2.95M 2.93%
258,642
+36,986
+17% +$494K
AERI
7
DELISTED
Aerie Pharmaceuticals
AERI
$2.94M 2.92%
165,669
+8,827
+6% +$160K
BEAT
8
DELISTED
BioTelemetry, Inc.
BEAT
$2.88M 2.86%
235,645
– –
PODD icon
9
Insulet
PODD
$11.1B
$2.75M 2.73%
106,018
– –
RIGL icon
10
Rigel Pharmaceuticals
RIGL
$763M
$2.74M 2.72%
110,974
– –
WINT
11
DELISTED
Windtree Therapeutics Inc
WINT
$2.25M 2.24%
536,325
+193,834
+57% +$1.28M
AGTC
12
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.07M 2.05%
157,192
– –
OTIC
13
DELISTED
Otonomy, Inc.
OTIC
$1.99M 1.97%
111,466
– –
MASI
14
DELISTED
Masimo
MASI
$1.77M 1.76%
46,010
– –
DSCI
15
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$1.68M 1.67%
356,918
-17,000
-5% -$110K
XNPT
16
DELISTED
XENOPORT, INC.
XNPT
$1.63M 1.62%
470,612
-60,420
-11% -$381K
SGYP
17
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.57M 1.56%
296,563
-21,000
-7% -$163K
EPIX
18
DELISTED
ESSA Pharma
EPIX
$1.42M 1.41%
+11,425
New +$1.59M
PLX icon
19
Protalix BioTherapeutics
PLX
$188M
$1.41M 1.4%
119,319
-3,760
-3% -$59.8K
CYTR
20
DELISTED
CytRx Corp
CYTR
$1.38M 1.37%
97,169
+47,033
+94% +$797K
TVRD
21
Tvardi Therapeutics
TVRD
$28.9M
$1.34M 1.33%
2,599
-928
-26% -$621K
NEOS
22
DELISTED
Neos Therapeutics, Inc
NEOS
$1.33M 1.32%
+63,400
New +$1.4M
STXS icon
23
Stereotaxis
STXS
$161M
$1.27M 1.26%
1,372,862
-343,216
-20% -$340K
CYAD
24
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$1.26M 1.25%
30,000
– –
ADVM
25
DELISTED
Adverum Biotechnologies
ADVM
$1.16M 1.15%
+14,060
New +$1.8M
1
2 3 4

Similar funds

FGWP
Founders Grove Wealth Partners Richmond, Virginia $440M AUM 16.56% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $440M AUM